UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

The New England journal of medicine, 2018-03, Vol.378 (13), p.1177-1188

2018

Volltextzugriff (PDF)

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

BMC cancer, 2008-03, Vol.8 (1), p.82-82, Article 82

2008

Volltextzugriff (PDF)

A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score

Internal and emergency medicine, 2012-06, Vol.7 (3), p.291-292

2012

Volltextzugriff (PDF)

Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial

Journal of clinical oncology, 2010-01, Vol.28 (3), p.466-474

2010

Volltextzugriff (PDF)

Addressing the challenges of pancreatic cancer: Future directions for improving outcomes

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2015-01, Vol.15 (1), p.8-18

2015

Volltextzugriff (PDF)

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

Journal of clinical oncology, 2010-07, Vol.28 (20), p.3219-3226

2010

Volltextzugriff (PDF)

Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

Journal of clinical oncology, 2009-02, Vol.27 (6), p.872-877

2009

Volltextzugriff (PDF)

Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy

Cancer, 2013-04, Vol.119 (8), p.1528-1536

2013

Volltextzugriff (PDF)

Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials

Journal of clinical oncology, 2008-10, Vol.26 (30), p.4906-4911

2008

Volltextzugriff (PDF)

FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial

Journal of clinical oncology, 2018-05, Vol.36 (15), p.1478-1485

2018

Volltextzugriff (PDF)

Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3

Journal of clinical oncology, 2009-07, Vol.27 (19), p.3117-3125

2009

Volltextzugriff (PDF)

Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies

Journal of clinical oncology, 2007-01, Vol.25 (3), p.326-331

2007

Volltextzugriff (PDF)

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1645-1651

2010

Volltextzugriff (PDF)

Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study

Journal of translational medicine, 2011-10, Vol.9 (1), p.179-179, Article 179

2011

Volltextzugriff (PDF)

Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort

Journal of thrombosis and haemostasis, 2023-07, Vol.21 (7), p.1869-1881

2023

Volltextzugriff (PDF)

ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer

JNCI : Journal of the National Cancer Institute, 2014-12, Vol.106 (12), p.1

2014

Volltextzugriff (PDF)

Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer

Haematologica (Roma), 2020-06, Vol.105 (6), p.1704-1711

2020

Volltextzugriff (PDF)

Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8664-8670

2005

Volltextzugriff (PDF)

Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?

Journal of clinical oncology, 2004-05, Vol.22 (10), p.1797-1806

2004

Volltextzugriff (PDF)

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine‐Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

The oncologist (Dayton, Ohio), 2019-03, Vol.24 (3), p.385-393

2019

Volltextzugriff (PDF)

End Points for Colon Cancer Adjuvant Trials: Observations and Recommendations Based on Individual Patient Data From 20,898 Patients Enrolled Onto 18 Randomized Trials From the ACCENT Group

Journal of clinical oncology, 2007-10, Vol.25 (29), p.4569-4574

2007

Volltextzugriff (PDF)

1 – 25 von 299

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(288)
Mit Volltextzugriff
(267)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(190)
Life Sciences & Biomedicine
(187)
Humans
(177)
Oncology
(142)
Female
(104)
Male
(99)
Aged
(90)
Middle Aged
(87)
Biological And Medical Sciences
(68)
Medical Sciences
(68)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(58)
Adult
(57)
Chemotherapy
(53)
Tumors
(49)
Treatment Outcome
(39)
Disease-Free Survival
(34)
Colorectal Cancer
(33)
Prognosis
(32)
Neoplasm Staging
(31)
Aged, 80 And Over
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score

Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial

Addressing the challenges of pancreatic cancer: Future directions for improving outcomes

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

Assessment of a HER2 scoring system for colorectal cancer: results from a validation study

Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy

Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials

FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial

Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3

Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study

Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study

Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort

ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer

Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer

Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine‐Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

End Points for Colon Cancer Adjuvant Trials: Observations and Recommendations Based on Individual Patient Data From 20,898 Patients Enrolled Onto 18 Randomized Trials From the ACCENT Group

Suchergebnisse filtern